Sono-Tek Corporation (OTCMKTS:SOTK) Files An 8-K Regulation FD Disclosure
Item 7.01: Regulation FD Disclosure
On August 11, 2020, Sono-Tek Corporation issued a press release regarding its application submission for uplisting its common stock to the NASDAQ Capital Market in the form attached as exhibit 99.1.
The information furnished to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01: Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated August 11, 2020.
SONO TEK CORP Exhibit
EX-99.1 2 ex99-1.htm FOR IMMEDIATE RELEASE Exhibit 99.1 FOR IMMEDIATE RELEASE Sono-Tek Submits Application for Uplisting to the NASDAQ Capital Market MILTON,…
To view the full exhibit click here
About Sono-Tek Corporation (OTCMKTS:SOTK)
Sono-Tek Corporation is engaged in the development, manufacture and sale of ultrasonic liquid atomizing nozzles. The Company utilizes its technology, ultrasonic spray coating, to provide customized coating solutions to a range of manufacturing companies, enabling to develop new products. The Company operates through two segments: ultrasonic spray coating systems, which is in the business of developing, manufacturing, selling, installing and servicing ultrasonic spray coating equipment, and real estate operations, which is in the business of owning and operating the Sono-Tek Industrial Park. The Company offers its products to a range of markets, including electronics, advanced energy (solar and fuel cells), medical device, glass, textiles and foods. The Company serves electronics industry in approximately two sectors, printed circuit board (PCB) manufacturing and semiconductor manufacturing. It offers products, such as SonoFlux 2000F, SelectaFlux, MediCoat I, Medicoat II and WideTrack.